Cargando…
New generations of dihydropyridines for treatment of hypertension
Since the calcium channel blocker (CCB) has become one of the most prescribed agents for antihypertensive monotherapy in the world, this brief review will focus on the recent research and development of the dihydropyridine (DHP) CCB, addressing pharmacological mechanisms for the clinical efficacy of...
Autores principales: | Wang, Angela L, Iadecola, Costantino, Wang, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329735/ https://www.ncbi.nlm.nih.gov/pubmed/28270844 http://dx.doi.org/10.11909/j.issn.1671-5411.2017.01.006 |
Ejemplares similares
-
The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design
por: Ling, Yong, et al.
Publicado: (2021) -
Effects of COVID-19 on the Nervous System
por: Iadecola, Costantino, et al.
Publicado: (2020) -
Repurposing Dihydropyridines for Treatment of Helicobacter pylori Infection
por: González, Andrés, et al.
Publicado: (2019) -
A New Generation of Dihydropyridine Calcium Channel Blockers: Photostabilization of Liquid Formulations Using Nonionic Surfactants
por: Ioele, Giuseppina, et al.
Publicado: (2019) -
3D Structure of the Dihydropyridine Receptor of Skeletal Muscle
por: Samsó, Montserrat
Publicado: (2015)